Evid Based Nurs 8:14 doi:10.1136/ebn.8.1.14
  • Treatment

Review: long term use of common medications for asthma reduces exacerbations in adults

Effectiveness of common pharmacological medications for asthma in adults at 3–39 months*

Outcome Comparison Number of trials (n) RRR (95% CI)
*ICSs  =  inhaled corticosteroids; SABAs  =  short acting β2 agonists; LABAs  =  long acting β2 agonists; LPMs/RAs  =  leukotriene pathway modifiers/receptor antagonists. Other abbreviations defined in glossary; RRR and CI calculated from data in article.
†Calculated using a random effects model.
Rate of exacerbations ICSs v placebo or SABAs 11 (9418) 54% (38 to 66)†
LABAs v placebo 9 (2854) 25% (12 to 36)
ICSs plus LABAs v ICSs 7 (3886) 26% (9 to 39)
ICSs plus LABAs v doubled dosage of ICSs 10 (5680) 14% (4 to 24)
LPMs/RAs v placebo 7 (4375) 41% (29 to 51)
ICSs plus anti-IgE antibodies v ICSs 3 (1388) 45% (34 to 55)

This Article

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article